Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs. We discuss 20-year-old male patient with NMS induce...
Saved in:
Published in | CHRISMED Journal of Health and Research Vol. 3; no. 2; pp. 141 - 143 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Medknow Publications and Media Pvt. Ltd
01.04.2016
Wolters Kluwer Medknow Publications |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition induced by neuroleptic medications. In severe cases, NMS can rapidly lead to death. NMS is reported less frequently now-a-days with the advent of new antipsychotic drugs. We discuss 20-year-old male patient with NMS induced by risperidone and quetiapin. |
---|---|
ISSN: | 2348-3334 2348-506X |
DOI: | 10.4103/2348-3334.177643 |